FDA Inspection 1326094 - Tomasz M. Ziedalski, M.D. - July 09, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Tomasz M. Ziedalski, M.D.

Record Details

This FDA Inspection record concerns Tomasz M. Ziedalski, M.D., with an inspection on July 9, 2026, issued by the Seattle District Office, covering human drugs.

Company: Tomasz M. Ziedalski, M.D.
Inspection Date: July 9, 2026
Product Type: Human Drugs
Office: Seattle District Office

Open in Dashboard

ID · 593f41e4-b954-4cae-a316-b814b34725b6

Violation Codes1

21 CFR 312.60

Full citation text and observation details available on the Dashboard.